Latest Insider Transactions at Aura Biosciences, Inc. (AURA)
This section provides a real-time view of insider transactions for Aura Biosciences, Inc. (AURA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aura Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aura Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 02
2021
|
Matrix Capital Management Company, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,327,870
+50.0%
|
-
|
|
Nov 02
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
710,000
+18.93%
|
$9,940,000
$14.0 P/Share
|
|
Nov 02
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,329,892
+50.0%
|
-
|
|
Nov 02
2021
|
David Michael Johnson |
BUY
Conversion of derivative security
|
Indirect |
139,672
+50.0%
|
-
|
|
Nov 02
2021
|
Pinos Elisabet De Los |
BUY
Conversion of derivative security
|
Indirect |
4,552
+3.35%
|
-
|
|
Oct 28
2021
|
Christopher Brett Primiano Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+50.0%
|
-
|
|
Oct 28
2021
|
Julie B Feder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+50.0%
|
-
|
|
Oct 28
2021
|
Mark De Rosch Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+50.0%
|
-
|
|
Oct 28
2021
|
Pinos Elisabet De Los |
BUY
Grant, award, or other acquisition
|
Direct |
74,357
+50.0%
|
-
|
|
Oct 28
2021
|
Cadmus Rich Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+50.0%
|
-
|